Category: Clinical Trials

January 19, 2021

After manufacturing cells in a bioreactor, bioprocessors need methods to capture that product. Using membranes and other conventional methods of separating the cells can lead to clogging, cost too much or just fail to be reliable. At the University of […]

January 13, 2021

Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce that it has successfully completed the development of its CDX antibody with a leading global pharmaceutical company (“GlobalCo”). As a result […]

January 11, 2021

Concern has been building about the new SARS-CoV-2 strain discovered last month in the U.K., and on Friday, the U.S. Food and Drug Administration (FDA) issued an official alert stating that it could trigger false negatives in COVID-19 tests. The […]

January 7, 2021

The Health Research Authority (HRA) has launched a new service offered to pharmaceutical companies and research organisations which will accelerate the ethics review stage of clinical trials approval. The HRA will offer the new swift review to global trials and […]

January 5, 2021

Transplanted stem cells have been used as regenerative therapies for decades. In cancer, for example, they can restore the body’s ability to create the red blood cells, white blood cells, and platelets after chemotherapy. But stem cells have wider therapeutic […]

December 31, 2020

ImmVira Group Company (“the Company”), a biotechnology platform dedicated to the development of oncolytic virus(“OV”) and vector type approaches to create more effective and safer therapies against cancer, announced today the signing of Series C financing. The Company’s rapidly advancing […]

December 23, 2020

A wide variety of cancer types have been linked to the misregulation of long noncoding RNA (lncRNA) genes. Now, a team from Cold Spring Harbor Laboratory (CSHL) showed that a particular lncRNA plays a role in mammary tumor cell proliferation, […]

December 21, 2020

The COVID-19 symptoms on the center stage are those associated with pneumonia and respiratory distress. But there are also a host of symptoms that relate to the central nervous system. Although it is unclear whether or not the SARS-CoV-2 virus […]

December 18, 2020

The effect of oral hormone therapy on the metabolome of postmenopausal women is profound. Different hormone therapy regimens result in discordant metabolomic effects that impact the risk for coronary heart disease, reports a study led by Raji Balasubramanian, associate professor […]

December 11, 2020

Results from a long-term study of a gene therapy technique to prevent inherited mitochondrial disease show promise, researchers say. Studies of the technique at Oregon Health & Science University in Portland show no adverse health effects in rhesus macaque monkeys […]

December 10, 2020

A recent study reveals a new cellular and molecular mechanism essential for the process of arterialization—the development of arteries from blood capillaries. Activation of this mechanism could improve the recovery of heart function after transient or long-term reduction in heart […]

December 9, 2020

A new study provides an explanation as to why cancer immunotherapy currently fails in many patients and offers a potential solution that could increase the efficacy of anticancer drugs. Currently, 70 to 85% of patients taking immunotherapy drugs fail to […]